Day One Biopharmaceuticals Inc (DAWN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 262,731 | 284,309 | 297,160 | 309,996 | 154,870 |
| TOTAL | $267,368 | $289,368 | $303,311 | $316,025 | $158,755 |
| Non-Current Assets | |||||
| PPE Net | 66 | 57 | 62 | 67 | 72 |
| Other Non-Current Assets | 345 | 396 | 410 | 445 | 2,053 |
| TOTAL | $411 | $453 | $472 | $512 | $2,125 |
| Total Assets | $267,779 | $289,821 | $303,783 | $316,537 | $160,880 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 701 | 1,744 | 683 | 348 | 686 |
| Accrued Expenses | 7,304 | 6,709 | 5,161 | 4,113 | 2,181 |
| TOTAL | $8,176 | $8,657 | $6,046 | $4,662 | $3,066 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 15 | 65 | 1,303 | 227,582 |
| TOTAL | $N/A | $16 | $65 | $112 | $226,663 |
| Total Liabilities | $8,176 | $8,673 | $6,111 | $4,774 | $229,729 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 61,912 | 61,952 | 61,929 | 61,929 | 50,429 |
| Common Shares | 6 | 6 | 6 | 6 | 2,000 |
| Retained earnings | -155,234 | -127,487 | -105,548 | -86,308 | -72,024 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 1,175 |
| TOTAL | $259,603 | $281,148 | $297,672 | $311,763 | $-68,849 |
| Total Liabilities And Equity | $267,779 | $289,821 | $303,783 | $316,537 | $160,880 |